NHCN, in partnership with the National Viral Hepatitis Roundtable (NVHR), hosted a virtual subject-matter expert panel and Q&A about the use of 340B in correctional institutions. The event was designed to provide information to correctional entities who are interested in utilizing the 340B drug pricing program to improve viral hepatitis treatment in their facilities. Webinar content includes an overview of 340B, key considerations for use of 340B in correctional health entities, and a panel of experts offering technical assistance and providing insight into what to expect when employing 340B in correctional facilities.

Click here to view the webinar recording


Adrienne Simmons, Director of Programs, National Viral Hepatitis Roundtable

Dr. Adrienne Simmons is a pharmacist and advocate who has clinical and administrative experience in hepatology, HIV, medication access, and 340B. She has experience in federal and state legislative advocacy and has served on national policy committees for the American Pharmacists Association and the American Society of Health-System Pharmacists.


Jeff Davis, Consultant, Baker Donelson

Mr. Davis provides clients with health care regulatory counsel on issues affecting health care providers, including Medicare and Medicaid billing and reimbursement. He assists hospitals, pharmacies, other health care providers, and vendors on issues related to the federal 340B drug pricing program, including enrollment; contracting; audits; compliance with 340B, Medicare, and Medicaid requirements; and self-disclosures.

Emily McCloskey, Director of Policy & Legislative Affairs, NASTAD

Emily represents state HIV and hepatitis programs to Congress, federal government and partners, and national and community stakeholders, as well as manages NASTAD’s Ryan White Program and Appropriations policy work. She is one of the experts supporting NASTAD’s 340B series for health department viral hepatitis programs.


Robert Lawrence, Medical Director, Alaska Department of Corrections

In this role, Dr. Lawrence has led the development of the hepatitis C screening and treatment program in the Alaska Department of Corrections. He is a member of the statewide Hepatitis in Alaska Work Group, a body tasked with developing treatment and linkage to care strategies in Alaska.

Pauline Marcussen, Administrator of Healthcare Services, Rhode Island Department of Corrections

Rhode Island Department of Corrections (RI DOC) is a combined jurisdiction (jail and prison on one campus) with an average daily census of 2,100 inmates. RI DOC has been using 340B pricing for approximately 18 months as an STI Clinic in partnership with the Rhode Island Department of Health.

Brandon Sis, Clinical Pharmacy Coordinator for Corrections, MMCAP Infuse

Brandon Sis has been a pharmacist specializing in corrections facilities with MMCAP Infuse for five years. He manages contracts with over 70 vendors that are available for nationwide use, and by any size of facility. Brandon also administers a correctional pharmacy networking forum for solution-sharing.